GB1577345A - Hydroxamic acid derivatives of use in the treatment of urolithiasis and pyelonephrosis - Google Patents

Hydroxamic acid derivatives of use in the treatment of urolithiasis and pyelonephrosis Download PDF

Info

Publication number
GB1577345A
GB1577345A GB888177A GB888177A GB1577345A GB 1577345 A GB1577345 A GB 1577345A GB 888177 A GB888177 A GB 888177A GB 888177 A GB888177 A GB 888177A GB 1577345 A GB1577345 A GB 1577345A
Authority
GB
United Kingdom
Prior art keywords
compound
group
acetohydroxamic acid
formula
represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB888177A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6707776A external-priority patent/JPS6029379B2/ja
Priority claimed from JP6707876A external-priority patent/JPS52151158A/ja
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of GB1577345A publication Critical patent/GB1577345A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB888177A 1976-06-10 1977-03-02 Hydroxamic acid derivatives of use in the treatment of urolithiasis and pyelonephrosis Expired GB1577345A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6707776A JPS6029379B2 (ja) 1976-06-10 1976-06-10 新規なヒドロキサム酸化合物およびこの化合物を主成分とする尿路結石症治療剤
JP6707876A JPS52151158A (en) 1976-06-10 1976-06-10 Novel hydroxamic acid compound and remedies for lithangiuria containing the same

Publications (1)

Publication Number Publication Date
GB1577345A true GB1577345A (en) 1980-10-22

Family

ID=26408270

Family Applications (1)

Application Number Title Priority Date Filing Date
GB888177A Expired GB1577345A (en) 1976-06-10 1977-03-02 Hydroxamic acid derivatives of use in the treatment of urolithiasis and pyelonephrosis

Country Status (3)

Country Link
DE (1) DE2709050A1 (enrdf_load_stackoverflow)
FR (1) FR2354315A1 (enrdf_load_stackoverflow)
GB (1) GB1577345A (enrdf_load_stackoverflow)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010031750A1 (en) * 2008-09-17 2010-03-25 Novartis Ag Organic compounds for applications in bacterial infections treatment
CN117510287A (zh) * 2023-12-01 2024-02-06 安徽司尔特化肥科技有限公司 一种小麦种植用高稳定肥料组合物及其制备方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283637B1 (it) * 1996-05-14 1998-04-23 Italfarmaco Spa Composti ad attivita' antinfiammatoria ed immunosoppressiva

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010031750A1 (en) * 2008-09-17 2010-03-25 Novartis Ag Organic compounds for applications in bacterial infections treatment
US8372885B2 (en) 2008-09-17 2013-02-12 Novartis Ag Organic compounds and their uses
CN117510287A (zh) * 2023-12-01 2024-02-06 安徽司尔特化肥科技有限公司 一种小麦种植用高稳定肥料组合物及其制备方法

Also Published As

Publication number Publication date
DE2709050A1 (de) 1977-12-29
FR2354315B1 (enrdf_load_stackoverflow) 1980-02-08
FR2354315A1 (fr) 1978-01-06

Similar Documents

Publication Publication Date Title
US4126635A (en) 2-amino-3-(5- and 6-)benzoylphenylacetic acids, esters and metal salts thereof
US4083996A (en) Novel hydroxamic acid derivatives and medicaments for treatment of urolithiasis and pyelonephrosis comprising such derivatives
JPS60158197A (ja) 抗生物質およびその製法
PL130553B1 (en) Process for preparing novel diester of methanediol with derivatives of penicillanic acid
US4157396A (en) Hydroxamic acid derivatives and medicaments for treatment of urolithiasis and pyelonephrosis comprising such derivatives
AU705447B2 (en) Eliminating agent for activated oxygen and free radicals
CN109503510B (zh) 一种防龋抗菌的噻唑类化合物及其制备方法
US4337258A (en) 2,4-Dioxo-4-substituted-1-butanoic acid derivatives useful in treating urinary tract calcium oxalate lithiasis
US4187315A (en) N-alkyl(and cycloalkyl)oxamic acid and derivatives as inhibitors of glycolic acid oxidase
US4423063A (en) 2,4-Dioxo-4-substituted-1-butaoic acid derivatives useful in treating urinary track calcium oxalate lithiasis
GB1577345A (en) Hydroxamic acid derivatives of use in the treatment of urolithiasis and pyelonephrosis
US4256765A (en) Novel hydroxamic acid compounds, method for preparation thereof and medicaments containing such compounds
WO2001030775A1 (en) Novel indole compounds
US4454126A (en) Phosphoramide derivatives and medicines containing the same
US4435420A (en) Anti-inflammatory agents and antiasthmatic agents
IE61325B1 (en) Crystalline salts of [3s(z)]-2[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1 -(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene] amino]oxy]acetic acid
JP3247695B2 (ja) エタノール摂取を妨げるチオカルバメートスルホキシド組成物
US4131683A (en) ω-(1,3-Dithiolan-2-imino) substituted acetic acids
CA1055927A (en) Method for preparation of aminomethylaryl-methylpenicillin derivatives
EP1384481A1 (en) Remedies for vesical hyperesthesia
US5091547A (en) Phenylacetic acid derivative and process for making same
US4009160A (en) Aminomethylarylmethylpenicillin derivatives
EP0572532B1 (en) Oxaza substituted phosphines
US4455312A (en) 2-(o-Carboxyphenylamino)-6H-pyrimido(2,1-b)-quinazolone-6 and derivatives thereof, and application as antiphlogistics
WO2002024197A1 (en) Fatty acid synthase inhibitors

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee